The proposals were cleared following recommendations from the Foreign Investment Promotion Board (FIPB) headed by Economic Affairs Secretary Arvind Mayaram, the Finance Ministry said.
The FIPB referred a proposal by Singapore-based KKR Floorline Investments to the Cabinet Committee on Economic Affairs (CCEA). Although the ministry did not mention an amount in this case, foreign investment proposals exceeding Rs 1,200 crore require the approval of the CCEA.
Also Read
Welspun Renewables Energy received approval to issue equity shares equivalent to a 13.3% stake to Asian Development Bank for Rs 310 crore ($50 million) and sell convertible debentures for Rs 220 crore ($35 million) to Deutsche Investitions- und Entwicklungsgesellschaft.
Cordlife Sciences India has been allowed to increase foreign equity participation up to 100% and to issue convertible preference shares.
Yes Regulatory Healthcare Service, Rajoo Bausano Extrusion, Eurecat India Catalyst Services and ZF India have been allowed to go ahead with their investment plans.
The KKR Floorline proposal, which has been referred to the CCEA, relates to investments in Gland Pharma and Gland Celsus Bio Chemicals.
The government rejected three investment proposals, including that of Gastaad Hotels, and deferred decisions on four.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)